Status | Study |
Recruiting |
Study Name: CER-001 Therapy as a Novel Approach to Treat Genetic Orphan Diseases Condition: Familial Hypoalphalipoproteinemia Date: 2016-02-17 Interventions: Drug: CER-001 Recombinant huma |
Completed |
Study Name: Short-term Effect of Extended-release Niacin on Endothelial Function. Condition: Hypoalphalipoproteinemia Date: 2013-09-10 Interventions: Drug: Niacin The study was randomized, double-blind, controlled, using a 2-way crossover design with bot |
Completed |
Study Name: Effect of High Protein Diet on Adiponectin and Inflammation Among Overweight and Obese Children Condition: Body Mass Index Quantitative Trait Locus 5 Disorder Tangier Disease Date: 2013-06-21 Interventions: Other: nutrition intervention Other Name: high protein diet |
Completed |
Study Name: Effect of High Protein Diet on Cardiovascular Diseases Risk Factors Among Overweight and Obese Children Condition: Body Mass Index Quantitative Trait Locus 7 Disorder Tangier Disease Date: 2013-06-21 Interventions: Other: nutrition intervention high protein diet |
Active, not recruiting |
Study Name: Mendelian Reverse Cholesterol Transport Study Condition: Cholesterol, HDL Lipid Metabolism, Inborn Errors Tangier D Date: 2013-01-30 Interventions: Drug: 3H-cholesterol bound to albumin up to 100 uCi of [3H]-cholesterol (containing approximately 0.2 mg |
Completed |
Study Name: High Protein Weight Loss Diet, High Sensitivity C-Reactive Protein and Cardiovascular Risks Among Obese Women Condition: Body Mass Index Quantitative Trait Locus 8 Disorder Tangier Disease Date: 2012-12-18 Interventions: Other: nutrition intervention high protein diet |
Completed |
Study Name: Tomato Consumption and High Density Lipoprotein-cholesterol Condition: Hypoalphalipoproteinemia Date: 2011-04-26 Interventions: Dietary Supplement: Tomato consumption |
Completed |
Study Name: High-Density Lipoprotein (HDL) Treatment Study Condition: Coronary Arteriosclerosis Hypoalphalipoproteinemias Date: 2007-04-05 Interventions: Drug: Atorvastatin; Fenofibrate; Niacin Atorvastatin 20 mg; Fenofibrate 200 mg; Niacin 2g used sequentia |
Recruiting |
Study Name: Causes and Natural History of Dyslipidemias Condition: Dyslipidemias Date: 2006-07-18 |
Completed |
Study Name: Quantitative Genetic Analysis of Lipid Research Clinic Family Data Condition: Cardiovascular Diseases Heart Diseases Coronary Disease Date: 2000-05-25 |